Patients facing severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections
with comorbidities, especially patients whose immune system is weakened have higher
chances to face severe outcomes. One of the main reasons behind the suppression of
the immune system is iatrogenic, in patients who have autoimmune diseases and/or had
an organ transplant. Although there are studies that are examining immunocompromised
and/or transplanted patients with COVID-19 infection, furthermore there is a limited
number of studies available which are dealing with COVID-19 in pregnant women; however,
it is unique and is worth reporting when these factors are coexisting. In this study,
we present the case of a 33-year-old Caucasian pregnant woman, who had a kidney transplant
in 2009 and contracted the SARS-CoV-2 virus on the 26th gestational week, in 2021.
After her infection, superimposed preeclampsia was diagnosed and due to the worsening
flowmetric parameters, she gave birth to a premature male newborn with cesarean section.
Our kidney transplant patient’s case highlights how COVID-19 disease can lead to preeclampsia
and artificial termination of gestation.
